FDA Letter API

BioStar Technology International, LLC

Letter data

Company
BioStar Technology International, LLC
Recipient
Ulysses L. Sheretov | President | BioStar Technology International, LLC | BioStar Technology International, LLC | 2912 Colorado Blvd | Los Angeles | , | CA | 90041 | United States
Issue date
2018-12-14
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
512757
Reference number
WL #24-17
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER BioStar Technology International, LLC MARCS-CMS 512757 — December 14, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: United Parcel Service Reference #: WL #24-17 Close-Out Letter Recipient: Recipient Name Ulysses L. Sheretov Recipient Title President BioStar Technology International, LLC BioStar Technology International, LLC 2912 Colorado Blvd Los Angeles , CA 90041 United States Issuing Office: United States Dear Mr. Sheretov: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter WL # 24-15 issued April 17, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Compliance Branch Director Office of Human and Animal Food Division of Human and Animal FeedWest 5 Content current as of: 02/04/2019